Blood pressure medication recall over cancer risk expanded for more losartan drugs




  • In Business
  • 2019-01-24 02:25:38Z
  • By USA TODAY
 

As part of a growing number of blood pressure drug recalls, Torrent Pharmaceuticals has expanded its recall of losartan medication over concerns it contains a carcinogen.

Torrent said six additional lots of losartan potassium and hydrochlorothiazide tablets contain trace amounts of the probable human carcinogen N-nitrosodiethylamine (NDEA), according to a notice shared Tuesday by the Food and Drug Administration.

The India-based pharmaceutical company has already recalled 10 lots of losartan potassium tablets in the past two months, and since July, more than a dozen other recalls have been issued for common blood pressure medications.

The recalls have been linked to two overseas factories that made the drugs' active ingredients, which the FDA has said it is investigating. The drugs have been found to contain either NDEA or N-Nitrosodimethylamine (NDMA).

Check your medication: Here's how to see if your blood pressure meds are recalled over possible cancer risk

Various versions of valsartan, losartan and irbesartan drugs have been part of the recalls. These medications are part of a large class called angiotensin II receptor blockers (ARBs), which lower blood pressure by widening or relaxing blood vessels.

However, not all ARBs contain NDMA or NDEA or are under recall, and alternative treatments or medications can be prescribed in consultation with physicians, the FDA says.

The agency is telling patients to continue taking their medication "as the risk of harm to the patient's health may be higher if the treatment is stopped immediately without any alternative treatment," the FDA said.

Q&A: Why do blood pressure medications keep getting recalled? Here's what to know.

Click here to find out if your medication is affected by the recent recalls, or visit the FDA website. The agency has updated lists for all three kinds of drugs affected by the recalls.

Contributing: Ken Alltucker, USA TODAY. Follow USA TODAY's Ryan Miller on Twitter: @RyanW_Miller

Alternatives: Blood pressure drug substitutes are available for patients affected by recalls, doctors say

This article originally appeared on USA TODAY: Blood pressure medication recall over cancer risk expanded for more losartan drugs

COMMENTS

More Related News

Kratom is not a cure for opioid addiction, FDA says in cracking down on illegal marketing
Kratom is not a cure for opioid addiction, FDA says in cracking down on illegal marketing

The FDA cited examples of two companies claiming that kratom can treat addiction, but the FDA hasn't approved the products for such uses.

How Walking 30 Minutes a Day Can Boost Weight Loss, Improve Digestion, and Help You Live Longer
How Walking 30 Minutes a Day Can Boost Weight Loss, Improve Digestion, and Help You Live Longer

Science says pounding pavement can do your body wonders.

Pig Farmers Seek Streamlined Reviews for GMO Pork
Pig Farmers Seek Streamlined Reviews for GMO Pork

(Bloomberg) -- Pork producers are stepping up their campaign to ease regulation of genetically engineered livestock following an executive order President Donald Trump issued earlier this month instructing federal agencies to speed up approval of new agricultural biotechnology.The National Pork Producers Council is seeking White House intervention to reverse a Food and Drug Administration stance that genetically edited animals should be regulated like drugs and barred from entering the food chain until the modifications are shown to be safe.The trade group wants the Department of Agriculture to be the lead oversight agency, maintaining that regulatory hurdles risk giving a competitive...

AbbVie Announces Lifting of FDA
AbbVie Announces Lifting of FDA's Partial Hold on CANOVA Study

AbbVie (ABBV) receives encouraging news as FDA lifts partial clinical hold on a late-stage study evaluating Venclexta in relapsed/refractory multiple myeloma.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business

facebook
Hit "Like"
Don't miss any important news
Thanks, you don't need to show me this anymore.